Autolus Therapeutics plc
AUTL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$79,115 | -$47,920 | -$70,161 | -$27,606 |
| Dep. & Amort. | $595 | $4,311 | $2,277 | $2,077 |
| Deferred Tax | $13 | $384 | $487 | $141 |
| Stock-Based Comp. | $3,835 | $4,293 | $2,867 | $6,233 |
| Change in WC | $40,620 | -$22,921 | -$17,699 | -$2,986 |
| Other Non-Cash | -$33,847 | -$10,928 | $6,664 | -$15,793 |
| Operating Cash Flow | -$67,899 | -$72,781 | -$75,565 | -$37,934 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $15,520 | -$7,277 | -$8,243 | -$11,112 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$82,939 | -$47,995 | -$71,304 | $0 |
| Inv. Sales/Matur. | $130,983 | $151,187 | $20,000 | $0 |
| Other Inv. Act. | -$28,017 | $0 | $0 | -$372,477 |
| Investing Cash Flow | $35,547 | $95,915 | -$59,547 | -$383,589 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,774 | -$768 | $0 | $30,007 |
| Financing Cash Flow | -$1,774 | -$768 | $0 | $30,007 |
| Forex Effect | -$3,583 | $5,715 | $3,558 | -$38,216 |
| Net Chg. in Cash | -$37,710 | $28,081 | -$131,554 | -$429,732 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $125,332 | $97,251 | $228,805 | $658,537 |
| End Cash | $87,622 | $125,332 | $97,251 | $228,805 |
| Free Cash Flow | -$52,379 | -$80,058 | -$83,808 | -$61,790 |